1
Clinical Trials associated with Human fibrinogen (Sinopharm Group Shanghai Blood Products)评价人纤维蛋白原治疗先天性纤维蛋白原缺乏症患者的药代动力学和有效性及安全性的单臂、开放、多中心临床研究
[Translation] A single-arm, open-label, multicenter clinical study to evaluate the pharmacokinetics, efficacy and safety of human fibrinogen in the treatment of patients with congenital fibrinogen deficiency
评价人纤维蛋白原治疗先天性纤维蛋白原缺乏症的有效性和安全性。
评价人纤维蛋白原治疗先天性纤维蛋白原缺乏症的药代动力学特征。
[Translation] To evaluate the efficacy and safety of human fibrinogen in the treatment of congenital fibrinogen deficiency.
To evaluate the pharmacokinetic characteristics of human fibrinogen in the treatment of congenital fibrinogen deficiency.
100 Clinical Results associated with Human fibrinogen (Sinopharm Group Shanghai Blood Products)
100 Translational Medicine associated with Human fibrinogen (Sinopharm Group Shanghai Blood Products)
100 Patents (Medical) associated with Human fibrinogen (Sinopharm Group Shanghai Blood Products)
100 Deals associated with Human fibrinogen (Sinopharm Group Shanghai Blood Products)